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To the Editor: This study aimed to assess the early effectiveness of a disease management 
program (DMP), called “Dimissione Protetta Difficile” (Di.Pro.Di) conducted by personnel from 
the intensive care unit (ICU) of Public Hospital S. Paolo, Naples, Italy. This hospital serves an 
area of 31λkm2 with 211,000 inhabitants (20.6% aged ≥65). This controlled nonrandomized trial 
aimed to stabilize patients fully with three home visits in the 3 months after discharge. 
Rehospitalizations and hospital length of stay of elderly patients suffering from congestive heart 
failure (CHF) after discharge from the ICU were focused on, because reducing these outcomes is 
a crucial challenge for developed countries because of their increasing elderly population. The 
literature shows that DMPs improve care.[1–3] Comparing these outcomes in treatment and 
control groups, using conventional statistic tests, it was observed, albeit in small numbers, that 
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Di.Pro.Di significantly reduces the number and risk of rehospitalizations and total hospital length 
of stay. 
METHODS 
Multidisciplinary teams evaluate patients and educate their families. Patients receive up to three 
domiciliary visits in the 3 months after discharge. Telephone communication integrates these 
visits. A physician evaluates the patient’s condition and, if there is mild deterioration, modulates 
the therapy or orders further investigations. If there is major deterioration, the patient is 
rehospitalized. If the patient health condition is stabile, he is fully discharged.[4] The group of 
patients enrolled in the program (treatment group, TG) were benchmarked with a group of 
patients hospitalized in the same structure but not enrolled in the program (control group, CG). 
The outcomes of a subset of patients enrolled in the TG were retrospectively analyzed. A t-test 
and a chi-square test with Yates’ correction were performed to assess the statistical significance 
of the results and the homogeneity between groups. 
Protocol 
Two hundred fifty patients were involved in the Di.Pro.Di, approximately 20 at any one time. 
Sixteen patients met the inclusion criteria: aged 65 and older, New York Heart Association 
classification II or III, high risk of rehospitalization, and adequate family support. 
The hospital provides the required predosed drugs. During each visit, a gerontologist or 
cardiologist and a nurse, supported by a car driver or orderly, perform and electrocardiogram, 
oximetry, blood-gas analysis, capillary blood glucose, and urinalysis. 
Oxygen therapy or pulmonary ventilation might also be required. After the third visit, the 
patient is discharged from the Di.Pro.Di and, according to the stability criteria, rehospitalized or 
transferred to local health services. 
RESULTS 
The results of this study are summarized in Table 1. 
Outcomes 
TG After Di.Pro.Di 
The TG included 16 patients with a mean age of 81.0±8.8. Four patients (25%) were 
rehospitalized, for a total of four rehospitalizations, (mean 0.3, maximum of one per patient). The 
total hospital length of stay was 17 days (mean total 1.1±2.1 days per patient). 
TG Before Di.Pro.Di 
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Six patients in the TG were investigated retrospectively for the year before the Di.Pro.Di. Five 
of them (83%) were rehospitalized, for a total of 11 rehospitalizations (mean 1.8 hospitalizations; 
maximum 4 per patient). Total hospital length of stay for these patients was 69 days (mean total 
11.5±7.2 days per patient). 
Control Group 
The CG included 18 patients with a mean age of 79.5±9.6. Eleven (61.1%) were rehospitalized, 
for a total of 17 rehospitalizations (mean 0.9, maximum 3 per patient). Total hospital length of 
stay was 234 days (mean total 13.0±7.7 days per patient). 
Homogeneity of TG and CG 
No statistically significant difference was observed between the CG and TG before Di.Pro.Di in 
terms of mean age, number of rehospitalizations, and hospital length of stay. In both groups, the 
number of rehospitalizations and hospital lengths of stay were slightly higher than reported in 
previous studies,[5,6] possibly because the mean age was slightly higher. 
Hospitalizations 
The risk of rehospitalization in the TG was 40% lower  (p=0.03) than in the CG. The ratio of the 
risk of rehospitalization, after the Di.Pro.Di and before, was 0.30  (p=0.009). 
Length of Stay 
The duration of hospital stay was 10.4 days shorter in the TG (P&lt;.001) than in the CG. The 
duration of hospital stay was in the TG was 11.9 days shorter after the Di.Pro.Di than before 
(P&lt;.001). 
 
Table 1. Rehospitalizations and Hospital Length of Stay According to Group in the 3 Months 
After Discharge 
Outcome Control Group 
(n=18) 
Treatment Group 





Patients rehospitalized 11 5 4 
Rehospitalizations 17 11 4 
Length of hospital stay 
Days per group, n 234 69 17 
Days per patient, mean±standard deviation 13.0±7.7 11.5±7.2 1.1±2.1 
*Di.Pro.Di: disease management program “Dimissione Protetta Difficile” (Di.Pro.Di.) 
CONCLUSION 
Di.Pro.Di significantly reduced number of rehospitalizations and hospital length of stay. A 
possible reason is that Di.Pro.Di allows patients to be fully stabilized before complete discharge. 
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As in other DMPs, Di.Pro.Di improved the education of patients and families, improving 
adherence to therapy and lifestyle after discharge. These preliminary results suggest that 
Di.Pro.Di. improves the effectiveness of care for elderly patients with CHF. 
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